Columbus McKinnon (NASDAQ:CMCO) reported its financial results for the fourth quarter and full fiscal year 2026 today, highlighting the substantial impact of its recent Kito Crosby acquisition.
MarketAxess Holdings (NASDAQ:MKTX) saw a broad rebound in trading volumes across most product categories during May 2026, recovering from levels recorded in April.
Somnigroup International (NYSE:SGI) announced today that its proposed acquisition of Leggett & Platt (NYSE:LEG) has cleared a significant regulatory hurdle.
X-energy (NASDAQ:XE) reported total revenues and grant income of $43.4 million for the first quarter of 2026, marking a 109% increase compared to the same period in 2025.
Alvotech (NASDAQ:ALVO) has officially resubmitted its Biologics License Applications (BLAs) to the U.S. Food and Drug Administration (FDA) for two of its lead biosimilar candidates: AVT05, a proposed biosimilar to Simponi and Simponi Aria (golimumab), and AVT06, a proposed biosimilar to Eylea (aflibercept) 2 mg.
111 (NASDAQ:YI) reported unaudited financial results for the first quarter of 2026 today, signaling the company's deepening transition toward a more lean and technology-oriented operating structure.
Bitcoin slid to its lowest level since January, falling to around $63,300 as broad selling pressure intensified and investors reassessed expectations for a recovery in the cryptocurrency market.
California cryptocurrency businessman Adam Iza, known online as “The Godfather,” has pleaded guilty to his role in a kidnapping conspiracy linked to a stolen bitcoin fortune valued at approximately $245 million.
Biogen (NASDAQ:BIIB) and UCB have announced the release of positive results from the Phase 3 PHOENYCS GO clinical trial evaluating dapirolizumab pegol (DZP), an investigational treatment for systemic lupus erythematosus (SLE).
Pharming Group (NASDAQ:PHAR) announced today that the U.S. Food and Drug Administration (FDA) has accepted its resubmitted supplemental New Drug Application (sNDA) for Joenja (leniolisib).
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
